Loading...

MGTX MEIRAGTX HOLDINGS PLC Product Launches 8-K Filing

MRGT

MGTX

MEIRAGTX HOLDINGS PLC

(MGTX)

2024 8-K

Financial Agreement Update

Share Repurchase Agreement

Financial Results Report

Collaboration Agreement

Financial Results Released

Financial Statements

Pre-Market Approval

Lease Agreement

Strategic Collaboration

FDA Designation Granted

Financial Results

Positive Study Results

Financial Results

Annual General Meeting

Financial Results Announcement

Amendment to Board Appointm...

Financial Results Announcement

Asset Purchase Agreement

Financial Results Announcement

Investment Agreement with S...

Agreement with Perceptive C...

Annual General Meeting

Financial Results Announcement

Private Placement

Resignation of Director

Financial Results Announcement

External Links:

MeiraGTx Holdings plc announced positive results from a clinical study of its gene therapy AAV-GAD for Parkinson's disease, showing significant improvements in motor function and quality of life for high-dose participants. The study involved 14 subjects and demonstrated an 18-point improvement in motor scores and notable quality of life enhancements after 26 weeks.

AI Assistant

MEIRAGTX HOLDINGS PLC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.